Lixa targets global biotech market

01/09/2022 - 16:01

Bookmark

Upgrade your subscription to use this feature.

Perth startup Lixa is on the path to commercialising medical research from the University of Western Australia after gaining backing from tech hub CERI and raising $2.2 million.

Subscribe to read this article.

Register or login now and receive unlimited access to our award-winning, unbiased and trusted
journalism. Your key to local business, news, insights and data.

Subscribe today for award-winning, unbiased and trusted journalism

Subscription Options